Instrument Inactif

Communiqués LAM IND Other OTC

Actions

US51280R1041

Recherche biotechnologique et médicale

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

22/12/21

Parallel Industries Inc. annonce ses résultats pour le troisième trimestre clos le 30 septembre 2021

Communiqués

29/12/21	EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)	AQ
29/12/21	EASTON PHARMACEUTICALS INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.	AQ
22/12/21	EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
22/12/21	EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
22/12/21	EASTON PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
13/06/19	Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update	GL
05/03/19	Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market	GL
05/02/19	Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives	GL
23/01/19	Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 30th, 2018 and Revenue for Quarter Ending December 31, 2018	GL
11/01/19	Easton Announces Status Updates on its $2,600,000 Framing Contract to Construct 150 Homes, Including New Additional Project	GL
02/01/19	Easton Pharmaceuticals Announces Signing and Commencement of $2,600,000 Framing Contract to Construct 150 Homes	GL
18/12/18	Easton Pharmaceuticals Completes Purchase of Development Project with Total Projected Profit in Excess of $30 Million	GL
12/12/18	Easton Pharmaceuticals Provides Company Update Including Hotel Acquisition in Toronto, BAYER Agreement and Casino Resort in Greece	GL
01/10/18	Easton Pharmaceuticals Is Short-Listed to Acquire an Interest in an Operating Casino and Hotel Resort in Loutraki, Greece with Revenues in Excess of 60 Million Euro Per Year	GL
27/09/18	Easton Pharmaceuticals Reaches Agreement to Take Over Hotel and $17,000,000 Real Estate Asset in Heart of Toronto, Canada	GL
29/08/18	Easton Pharmaceuticals to Participate in a Casino and Hotel Resort Project in Europe with Projected Revenues in Excess of 77 Million Euro Per Annum	GL
20/08/18	Easton Pharmaceuticals Acquires Interest in Development Project With in Excess of $30 Million in Profit	GL
25/06/18	Easton Pharmaceuticals Strengthens its Board of Directors While Enhancing Existing Businesses and Moves Towards New Sectors and Industries	GL
20/06/18	Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction	GL
11/06/18	Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations	GL
04/06/18	Easton Pharmaceuticals Announces That Revenue Generating Operations Have Commenced From Its Alliance Property and Businesses	GL
16/04/18	Easton Pharmaceuticals Announces BAYER Agreement Update	GL
21/03/18	Easton Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency Initiative	GL
14/03/18	Easton Pharmaceuticals Announces It Has Commenced Negotiations With An AMPR Applicant Towards a Marijuana Cultivators / Growers License For Canada; Provides iBliss Update	GL
20/02/18	Easton Pharmaceuticals Announces Key Management Addition With the Appointment of Dr. Daniel Bagi, M.D. to the Board of Directors; Provides Other Updates	GL